Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer

Academic Article

Publication Date:

2016

Iris type:

Articolo su Rivista

Keywords:

Antineoplastic Combined Chemotherapy Protocols; Humans; Male; Prostatic Neoplasms, Castration-Resistant

List of contributors:

Authors of the University:

PERLETTI GIANPAOLO

Handle:

Published in:

Journal